Owhofasa Agbedia, MD, MPH, FACP
@fasaagbedia
Hematologist/Medical Oncologist | Interest in hematological malignancies | Tweets/opinions are mine ≠ medical advice #CART #Lymphoma #lymsm
ID: 1362315860
18-04-2013 16:14:29
357 Tweet
841 Takipçi
2,2K Takip Edilen
Inhibiting EZH1/2 increases the efficacy of CAR-T and TCR-T cells in preclinical models of both liquid and solid cancers. Kudos to Marco Ruella & team! cell.com/cancer-cell/fu…